Rapid Evacuation and Access of Cerebral Hemorrhage Trial
Part of paid clinical trials in Little Rock, Arkansas.
- Sponsor
- Emory University
- Study ID
- NCT06870812
- Status
- Recruiting
Conditions
- Stroke Hemorrhagic
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 70 Years
- Healthy Volunteers
- Not accepted
Interventions
- Surgical management — PROCEDUREFollowing randomization into the surgical arm, a competency-trained neurosurgeon will perform the MIPS for clot evacuation with strict adherence to the Surgical Manual of the CSG. Image interpretation, patient position, anesthetic plan, stereotactic navigation registration, exoscopic positioning, access, optics, resection, and hemostasis are detailed in the Surgical Manual of the CSG. The OR arrival time should occur \<24 hours from the last known normal (LKN) with a goal of arrival in less than 8 hours from the last known normal.
- Medical Management — OTHERFollowing randomization into the medical arm patients will be treated following the Medical Manual of the CSG. The Medical Manual has been adapted by the REACH Executive Committee (REC) from the current American Heart Association (AHA) and American Stroke Association (ASA) Guidelines for the Management of Spontaneous Intracerebral Hemorrhage. Whenever clinically feasible, the CSG should be followed as it represents a template for the care of these subjects. The Medical Manual details specialty level of care, including intensive care placement, blood pressure control, hemostasis and coagulopathy, anemia, deep venous thrombosis and pulmonary embolism prophylaxis/treatment, glucose management, temperature management, seizure prophylaxis, intracranial pressure monitoring and management, intraventricular hemorrhage (IVH)/obstructive hydrocephalus management, cerebral edema, decompressive hemicraniectomy, nutritional support, respiratory support, and comfort care.
Study Details
The main purpose of this study is to compare patients with a deep bleed in the brain undergoing surgery to patients receiving routine medical care. The standard treatment involves admission to the Intensive Care Unit (ICU) with close monitoring and blood pressure control. It also includes other medical (non-surgical) treatments to prevent more bleeding or another stroke. Sometimes, doctors will recommend surgery to remove the blood if medical treatment alone is not successful. There is evidence that doing minimally invasive surgery early-using a small opening in the skull to remove blood-may help some patients. Researchers aim to understand whether this surgery is better than current medical treatment, which may include surgeries to relieve pressure on the brain in some cases. This study, called REACH, is comparing usual medical care to early minimally invasive surgery so doctors can know which is better for patients.
Key Dates
- Start date
- May 27, 2025
- Status verified
- Mar 2026
- Primary completion
- Mar 31, 2030
- Completion
- Mar 31, 2030
Study Design
- Enrollment
- 600 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Surgical management (MIPS) plus medical managementParticipants randomized to surgical management will follow the Medical Manual of the Clinical Standardization Guidelines (CSG) before and after surgery.
- Active Comparator: medical management.Participants randomized to the medical management alone will be treated according to the Clinical Standardization Guidelines (CSG).
Primary Outcome Measure
Score on the modified Rankin Scale (mRS) at [ Time Frame: 180 days after randomization ]
Central Contacts
- Alex Hall, DHSc404-778-1585
Locations (21)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Arkansas for Medical Sciences | Little Rock | Arkansas | 72205 | Kennetha Newman Deanna Sasaki-Adams, MD (PRINCIPAL_INVESTIGATOR) |
| Stanford University Medical Center | Palo Alto | California | 94304 | Bharati Sanjawala Robert Dodd, MD (PRINCIPAL_INVESTIGATOR) |
| Baptist Health Jacksonville FL | Jacksonville | Florida | 32207 | Ricardo Hanel, MD, PhD (PRINCIPAL_INVESTIGATOR) |
| Baptist Health South Florida | Kendall | Florida | 33176 | Ahmed A Abdelsalam Robert Starke, MD (PRINCIPAL_INVESTIGATOR) |
| Jackson Memorial Hospital (JMH) | Miami | Florida | 33125 | Ahmed Abdelsalam Robert Starke, MD (PRINCIPAL_INVESTIGATOR) |
| Emory Hospital Midtown | Atlanta | Georgia | 30308 | Tomas Garzon-Muvdi, MD (PRINCIPAL_INVESTIGATOR) |
| Emory University Hospital (EUH) | Atlanta | Georgia | 30322 | Brian Howard, MD (PRINCIPAL_INVESTIGATOR) |
| Grady Memorial Hospital | Atlanta | Georgia | 30303 | Aqueel Pabaney, MD (PRINCIPAL_INVESTIGATOR) |
| Rush University | Chicago | Illinois | 60612 | Webster Crowley, MD, FAANS (PRINCIPAL_INVESTIGATOR) |
| Endeavor Health, Northshore | Evanston | Illinois | 60201 | Shakeel Chowdhry, MD (PRINCIPAL_INVESTIGATOR) |
| Goodman Campbell Brain and Spine | Carmel | Indiana | 46032 | Charles Kulwin, MD (PRINCIPAL_INVESTIGATOR) |
| University of Kentucky | Lexington | Kentucky | 40536 | Rachel Norris David Dornbos (PRINCIPAL_INVESTIGATOR) |
| Johns Hopkins School of Medicine | Baltimore | Maryland | 21287 | Whitney Isennock Justin Caplan, MD (PRINCIPAL_INVESTIGATOR) |
| University of Missouri | Columbia | Missouri | 65212 | Brooke Hoffman Michael Chicoine, MD (PRINCIPAL_INVESTIGATOR) |
| Albany Medical Center | Albany | New York | 12208 | Chelsey Large Alexandra Paul, MD (PRINCIPAL_INVESTIGATOR) |
| SUNY Upstate Medical University | Syracuse | New York | 13210 | Timothy Beutler, MD, FAANS (PRINCIPAL_INVESTIGATOR) |
| Montefiore Medical Center/Albert Einstein School of Medicine | The Bronx | New York | 10467 | Lavinia Williams |
| The Ohio State University | Columbus | Ohio | 43210 | Edouard Belizaire Patrick Youssef (PRINCIPAL_INVESTIGATOR) |
| ProMedica Toledo Hospital | Toledo | Ohio | 43606 | Melanie Pakulski Kevin Reinard, MD (PRINCIPAL_INVESTIGATOR) |
| Rhode Island Hospital/Brown University Health | Providence | Rhode Island | 02912 | Mei Tiemeyer Krisztina Moldovan, MD (PRINCIPAL_INVESTIGATOR) |
| Vanderbilt University Medical Center | Nashville | Tennessee | 37232 | Anna Bican Matthew Fusco, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Little Rock, AR
Related Studies
- Vision Loss Impact on Navigation in Virtual RealityRecruiting · University of Rochester · Rochester, New York
- The REACTplusNMES Trial: A Double-blinded RCTRecruiting · University of Illinois at Chicago · Chicago, Illinois
- Statistical Learning as a Novel Intervention for Cortical BlindnessEnrolling By Invitation · University of Rochester · Rochester, New York
- Use of Physical Therapy Outcome Measures to Predict Discharge Destination in People With Stroke From Acute Care HospitalNot Yet Recruiting · New York Presbyterian Brooklyn Methodist Hospital · Brooklyn, New York